Circulating adipokines level and the risk of neurodegenerative diseases: a two‑sample mendelian randomization study
Wenxian Sun1,2, Heya Luan1, Shaoqi Li3
1Department of Neurology, Innovation Center for Neurological Disorders, Xuanwu Hospital, National Clinical Research Center for Geriatric Diseases, Capital Medical University, No. 45 Changchun Street, Xicheng District, Beijing, 100053, China.
BMC Neurology
|January 16, 2026
Abstract
No abstract available in PubMed .
Keywords:
AdipokinesAlzheimer’s diseaseMendelian randomizationNeurodegenerative diseasesProteomic analysisMore Related Videos
07:08A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
8.2K
10:51Consensus Brain-derived Protein, Extraction Protocol for the Study of Human and Murine Brain Proteome Using Both 2D-DIGE and Mini 2DE Immunoblotting
Published on: April 10, 2014
16.7K
